Browse the evidence

A one standard deviation higher polygenic score (PS) related to a smaller one-year change in waist circumference adjusted for body mass index (WCadjBMI) in the lifestyle intervention arms at year 1, predicting poorer response among White participants overall.

Practitioners should consider genetic factors when assessing weight loss responses in individuals.

The effect of polygenic risk on change in WCadjBMI with lifestyle intervention is small and not of sufficient magnitude to be clinically significant.

Genetic factors may play a role in weight loss, but their impact may not be significant enough to warrant changes in intervention strategies.

Modern pharmacotherapies are fundamental to CKD prevention.

Incorporate modern pharmacotherapies into CKD prevention strategies.

The Mediterranean Adequacy Index (MAI) is inversely correlated with the Atherogenicity (ATI) index (R = -0.91).

Practitioners should consider the MAI as a significant dietary factor in cardiovascular health.

Atherogenicity (ATI) is directly correlated with serum cholesterol (R = +0.73).

Practitioners should monitor serum cholesterol levels in relation to dietary fatty acid intake.

Atherogenicity (ATI) and Thrombogenicity (THI) indices are strongly associated with long-term coronary heart disease (CHD) mortality.

Practitioners should consider the impact of dietary fatty acids on long-term CHD risk.

The FDA-approved label for resmetirom does not require liver biopsy to confirm the diagnosis of fibrotic MASH.

Clinicians can diagnose fibrotic MASH without the need for invasive liver biopsy, simplifying patient assessment.

SCD1 inhibitors have been developed to treat various types of cancer.

SCD1 inhibitors could be a promising avenue for cancer therapy.

There are existing knowledge gaps in the molecular adaptations to exercise that warrant continued research effort.

Researchers should focus on addressing these knowledge gaps to advance the field.

Higher plasma concentrations of TMAO are associated with a 30% increased risk of death from any cause among older adults.

Practitioners should consider monitoring TMAO levels in older adults as a potential risk factor for mortality.

Choline is associated with a 19% increased risk of death from any cause among older adults.

Monitoring choline levels may also be relevant for assessing mortality risk in older adults.

Carnitine and butyrobetaine are each associated with a 26% increased risk of death from any cause among older adults.

Practitioners should be aware of the potential risks associated with elevated levels of carnitine and butyrobetaine in older adults.

Reduced microbial diversity in the gut is implicated in several gastrointestinal diseases and cancers.

Maintaining gut microbiome diversity may be crucial for preventing gastrointestinal diseases.

Tirzepatide does not seem to have a classical co-activating mode of action in humans.

Understanding the unique action of tirzepatide may inform treatment strategies for type 2 diabetes.

Inhibition of miR-155 expression in macrophages improves EPC viability and reduces inflammation.

Targeting miR-155 may be a therapeutic strategy to enhance endothelial repair in obesity.

Semaglutide attenuated cardiac inflammation through restoring RKIP expression and inhibiting the TBK1-NF-κB pathway.

Understanding this mechanism can help in developing targeted therapies for cardiac inflammation in diabetes.

Semaglutide's anti-inflammatory effect is mediated through the Sirt3-dependent RKIP pathway, rather than glucose lowering.

This suggests that semaglutide may have benefits beyond just lowering blood sugar in diabetic patients.

Fatty acids increase GDF15 levels dose dependently, with the greatest response observed with linolenic acid.

Incorporating fatty acids like linolenic acid may enhance GDF15 levels, potentially influencing dietary responses.

There is a significant difference in the profile of reporting risk and time-to-onset of GADRs between semaglutide and liraglutide.

Understanding these differences can help tailor obesity treatment to individual patient needs.

Ingestion of deuterated water results in 2 H enrichment of the body water pool, which is incorporated into tissue proteins.

This highlights a novel approach to studying protein synthesis in muscle tissue.

Ex-DARPin fusion proteins have a comparable half-life of 29-32 hours, which is much longer than that of native Ex (0.5 hours in rats).

Longer half-life of Ex-DARPin fusion proteins may reduce the frequency of administration needed for effective treatment.

Promising candidates such as danuglipron and lotiglipron were discontinued due to hepatotoxicity.

Practitioners should be aware of safety concerns associated with certain GLP-1 receptor agonists.

Mendelian randomisation did not find evidence that genetically proxied GLP-1RA increased suicide attempts in a general population cohort.

There is no genetic evidence to support an association between GLP-1RA and increased suicide attempts, suggesting safety in this regard.

Artificial intelligence (AI) is a pivotal tool in drug discovery for developing next-generation anti-obesity therapeutics.

Practitioners should consider integrating AI tools in their drug discovery processes for obesity treatments.